SCHEMBL6178959

SCHEMBL6178959

CS(=O)(=O)CNc1cccnc1NC(=O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.53
NPC1 O15118 4/20 0.53
HTT P42858 1/20 0.51
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
KDR P35968 1/20 0.48
ATM Q13315 1/20 0.47
HDAC1 Q13547 2/20 0.43
HDAC3 O15379 1/20 0.42
MAPK1 P28482 1/20 0.42
HDAC2 Q92769 1/20 0.42
POLB P06746 1/20 0.42
HPGD P15428 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174461 0.84 HTT (0.56) RAB9ANPC1HTTMEN1KMT2A
SCHEMBL6175959 0.81 HTT (0.55) RAB9ANPC1HTTMEN1KMT2A
SCHEMBL19476169 0.77 RAB9A (0.64) RAB9ANPC1HTTMEN1KMT2A
SCHEMBL30648563 0.74 RAB9A (0.88) RAB9ANPC1HTTMEN1KMT2A
SCHEMBL23566407 0.74 HTT (0.63) RAB9ANPC1HTTMEN1KMT2A
SCHEMBL7532358 0.73 KMT2A (0.68) RAB9ANPC1HTTMEN1KMT2A
SCHEMBL14439750 0.73 NPC1 (0.61) RAB9ANPC1HTTMEN1KMT2A
SCHEMBL10814316 0.72 HDAC1 (0.59) RAB9ANPC1HTTKDRHDAC1
SCHEMBL14635929 0.71 HTT (0.60) RAB9ANPC1HTTMEN1KMT2A
SCHEMBL9694179 0.71 KDR (0.53) RAB9ANPC1HTTKDRATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575918-A2 SUBSTITUTED BIARYL-4-CARBOXYLIC ACID ARYLAMIDE ANALOGUES AS CAPSAICIN RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2005-09-21 EP claimed
WO-2004056774-A2 SUBSTITUTED BIPHENYL-4-CARBOXYLIC ACID ARYLAMIDE ANALOGUES AS CAPSAICIN RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2004-07-08 WO claimed